Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction.
about
Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines.Circulating complement-C1q TNF-related protein 1 levels are increased in patients with type 2 diabetes and are associated with insulin sensitivity in Chinese subjectsPlasma level of adrenomedullin is influenced by a single nucleotide polymorphism in the adiponectin geneWhat is the role of adiponectin in obesity related non-alcoholic fatty liver disease?Adipokines and hepatic insulin resistanceA novel fasting blood test for insulin resistance and prediabetes.Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease.The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer's Disease.Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway.Lipopolysaccharide-binding protein cannot independently predict type 2 diabetes mellitus: A nested case-control study.Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes.Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis.
P2860
Q33628222-C4CAB8C8-4CC9-4D3D-B7CD-EB0BB6C4C723Q33679354-C7C08D2F-8BD8-4EE5-9E2C-806838F909ACQ34925433-515A5BAE-5548-46B7-91EA-36B419408F09Q36616784-33650A6F-8E42-4A25-8176-94D422ABEE0EQ36896425-CC636CDB-14BA-4D4A-829C-C36FA7410F44Q36954280-09A97B9C-1469-41BA-BD3C-1D529BAC12D1Q37073866-95479FB5-5668-4DCF-B3A6-05200CF412A2Q37566373-A9CED0B0-58C2-43ED-8A3A-33123F840306Q40104945-2A021D08-9C2E-4BA4-B072-0EF3C152B5D3Q41263976-2CA4D48A-5100-4F28-B8CB-D20E7D0DA8FCQ48521781-B46C40EE-AFC3-45C1-B548-75908FF44FCEQ49438496-49E034AD-DE98-467B-A201-1A00A36A8132
P2860
Combined use of serum adiponectin and tumor necrosis factor-alpha receptor 2 levels was comparable to 2-hour post-load glucose in diabetes prediction.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Combined use of serum adiponec ...... lucose in diabetes prediction.
@ast
Combined use of serum adiponec ...... lucose in diabetes prediction.
@en
Combined use of serum adiponec ...... lucose in diabetes prediction.
@nl
type
label
Combined use of serum adiponec ...... lucose in diabetes prediction.
@ast
Combined use of serum adiponec ...... lucose in diabetes prediction.
@en
Combined use of serum adiponec ...... lucose in diabetes prediction.
@nl
prefLabel
Combined use of serum adiponec ...... lucose in diabetes prediction.
@ast
Combined use of serum adiponec ...... lucose in diabetes prediction.
@en
Combined use of serum adiponec ...... lucose in diabetes prediction.
@nl
P2093
P2860
P1433
P1476
Combined use of serum adiponec ...... lucose in diabetes prediction.
@en
P2093
Annette W K Tso
Carol H Y Fong
Karen S L Lam
Lawrence S C Law
Nelson M S Wat
Tai-Hing Lam
Yu-Cho Woo
P2860
P304
P356
10.1371/JOURNAL.PONE.0036868
P407
P577
2012-05-16T00:00:00Z